Product Details
Invokana
Canagliflozin100 mg
Tablet
DIN/PIN/NPN
02425483
Manufacturer
Janssen Inc.
Formulary Listing Date
2015-07-29
Unit Price
2.8910
Amount MOH Pays
1.4455
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Canagliflozin 100 mg Tablet:
Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have:
. Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR
. Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.
ATC Code
A10BK02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02425483 | Invokana | 2.8910 | 1.4455 |
| 02510367 | Auro-Canagliflozin | 1.4455 | 1.4455 |
| 02543486 | Jamp Canagliflozin | 1.4455 | 1.4455 |
LU Clinical Criteria
NORequirements